Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,577 | -82,642 | -57,217 | -27,059 | -118,181 |
| Depreciation Amortization | 1,916 | 1,376 | 953 | 493 | 2,412 |
| Accounts payable and accrued liabilities | 945 | -1,659 | 233 | 294 | -2,426 |
| Other Working Capital | 987 | -284 | 642 | -1,757 | 4,683 |
| Other Operating Activity | 21,338 | 18,816 | 11,330 | 4,864 | 19,483 |
| Operating Cash Flow | $-84,391 | $-64,393 | $-44,059 | $-23,165 | $-94,029 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -45 | -45 | -39 | -1,416 |
| Purchase Of Investment | -134,700 | -122,681 | -87,033 | -59,003 | -305,192 |
| Sale Of Investment | 159,365 | 140,719 | 110,046 | 65,793 | 215,867 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -82 |
| Investing Cash Flow | $24,595 | $17,993 | $22,968 | $6,751 | $-90,823 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 51,203 | 31,915 | 436 | 196 | 92,700 |
| Other Financing Activity | -39 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $51,164 | $31,915 | $436 | $196 | $92,700 |
| Exchange Rate Effect | -66 | 35 | 14 | 48 | -99 |
| Beginning Cash Position | 58,840 | 58,358 | 58,358 | 58,358 | 150,609 |
| End Cash Position | 50,142 | 43,908 | 37,717 | 42,188 | 58,358 |
| Net Cash Flow | $-8,698 | $-14,450 | $-20,641 | $-16,170 | $-92,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,391 | -64,393 | -44,059 | -23,165 | -94,029 |
| Capital Expenditure | -70 | -45 | -45 | -39 | -1,416 |
| Free Cash Flow | -84,461 | -64,438 | -44,104 | -23,204 | -95,445 |